In Drosophila, a complex consisting of Calypso and ASX catalyzes H2A deubiquitination and has been reported to act as part of the Polycomb machinery in transcriptional silencing. The mammalian homologs of these proteins (BAP1 and ASXL1/2/3, respectively), are frequently mutated in various cancer types, yet their precise functions remain unclear. Using an integrative approach based on isogenic cell lines generated with CRISPR/Cas9, we uncover an unanticipated role for BAP1 in gene activation. This function requires the assembly of an enzymatically active BAP1-associated core complex (BAP1.com) containing one of the redundant ASXL proteins. We investigated the mechanism underlying BAP1.com-mediated transcriptional regulation and show that it functions neither in synergy nor by antagonism with the Polycomb machinery. Instead, our results provide compelling evidence that BAP1.com acts as a general transcriptional co-activator.
INTRODUCTION
BAP1 (BRCA1 Associated Protein 1) was initially characterized as a nuclear deubiquitinase regulating the function of BRCA1 1 . Subsequent work suggested that BAP1 does in fact interact with BARD1
(BRCA1-associated RING domain 1) and regulates its ubiquitination 2 . Since then, a variety of proteins have been reported to interact with BAP1, including transcription factors (YY1, FOXK1/2), chromatin binders and modifiers (ASXL1/2/3, KDM1B, OGT1), the cell cycle regulator HCFC1 and DNA repair proteins (MBD5/6) [3] [4] [5] [6] [7] [8] [9] . BAP1 enzymatic activity has been shown to regulate the ubiquitination of various proteins including gamma-tubulin 10 , INO80 11 or BRCA1 1 . Accordingly, BAP1 participates in diverse cellular processes, such as transcriptional regulation and the DNA damage response. However, the precise function of BAP1 in transcriptional regulation remains elusive; for instance, some studies have reported that BAP1 acts as a transcriptional activator while others have suggested that it is required for gene silencing 3, 4, 12 .
In parallel to its characterization in mammals, studies in Drosophila identified the BAP1 ortholog Calypso as a novel Polycomb protein 13, 14 . The Polycomb Group (PcG) of proteins is essential for the maintenance of gene repression, most prominently at developmentally regulated genes. Consequently, altering PcG function affects key cellular processes such as cell fate determination, cell proliferation, and genomic imprinting 15 . Two Polycomb complexes have been well characterized so far: the Polycomb Repressive Complex 1 (PRC1) and PRC2. PRC2 catalyzes di-and trimethylation of histone H3 on lysine 27 (H3K27me2/3), while PRC1 acts through chromatin compaction and monoubiquitination of histone H2A on lysine 119 (H2AK119ub1) 16, 17 . Conserved from Drosophila to mammals, the activity of these complexes is necessary for maintaining transcriptional silencing of their target genes. The importance of H2AK119ub1 in Polycomb silencing has recently been called into question in Drosophila 18 as well as in mouse models 19 . Nonetheless, recent studies suggest that this mark participates in stabilizing PRC2 binding to chromatin 20, 21 .
In this study, we used biochemical, genome-editing, and genome-wide approaches to address the function of BAP1 in transcriptional regulation and its relationship to the Polycomb machinery. We show that the ASXLs are mandatory partners of BAP1 and that they are required for its stability and its enzymatic activity. At the functional level, the complex formed around BAP1 (BAP1.com) is required for efficient transcription of many developmental genes, a function that depends on the deubiquitinase (DUB) activity. Accordingly, BAP1 appears to be largely dispensable for maintaining silencing of Polycomb-target genes and in fact opposes PRC2-mediated silencing at a number of genes. The majority of BAP1-regulated genes, however, are not under regulation by PRC2, suggesting that the function of BAP1 in promoting transcription does not reflect an antagonism with Polycomb proteins.
Indeed, we show that BAP1 is required upon transcriptional stimulation as observed upon retinoic acid treatment, a function that is shared with the CREBBP and SMARCB1 transcriptional co-activators. A general role in regulating gene expression is supported by the conspicuous co-localization between BAP1.com and the RNA polymerase 2. Altogether, our integrative analysis uncovers an essential function for BAP1.com as a transcriptional co-activator.
RESULTS

BAP1 inactivation alters the expression of developmentally regulated genes
In order to comprehend the role of BAP1 in transcriptional regulation, we generated knockouts for BAP1, ASXL1, ASXL2, and EZH2, encoding the main catalytic subunit of PRC2, in human HAP1 cells, a model cell line that is nearly haploid and thus particularly amenable to genome editing 32 . Knockouts (KO) result from the insertion of a STOP cassette that interrupts transcription and translation of the target gene 33 and were validated by RT-qPCR ( Figure 1A) . Notably, in contrast to many cell lines where the knockdown of BAP1 severely compromises proliferation ( Figure S1A ), we found that BAP1
is dispensable for proliferation in HAP1 cells, thus providing a suitable system for studying its mechanism of action ( Figure 1B ). Cellular fractionation confirmed the tight association of BAP1 with chromatin, as shown by its enrichment both in the soluble and insoluble fractions ( Figure S1B ), which prompted us to further investigate its chromatin-modifying activity. Western blot analysis of various histone marks showed that BAP1 loss is associated with an approximate 2-fold increase in total H2A
ubiquitination levels, as well as a parallel increase in H2A.Z ubiquitination, with no effect on H2B ubiquitination ( Figure 1C , top panel). ASXL1 and ASXL2 KO led to a milder increase in H2A/H2A.Z ubiquitination. We did not find any global effect of knocking out BAP1, ASXL1, or ASXL2 on other histone marks such as H3K4me2 and H3K27me3 or on DNA modifications ( Figure 1C , bottom panel).
We then performed RNA-seq to analyze the transcriptome of wild-type and KO cell lines. The inactivation of BAP1 leads to dramatic changes in gene expression (1893 differentially expressed -DE genes, FDR < 0.05 and absolute log2 fold-change > 1; Figure 1D , left panel). Strikingly, a majority of the affected genes were downregulated in BAP1 KO cells (n=1370), suggesting an involvement in gene activation rather than silencing. Gene ontology (GO) analysis revealed enrichment for a variety of biological processes ranging from broad terms such as cell communication, signaling, or regulation of proliferation to more specific terms such as blood vessel development ( Figure 1D , right panel).
Importantly, several terms related to development are also found enriched, which is consistent with the reported function of the BAP1 ortholog in Drosophila 13 . Inactivation of either ASXL protein also leads to preferential downregulation of genes (85 downregulated genes out of 112 DE genes in ASXL1 KO cells and 262 downregulated genes out of 406 DE genes in ASXL2 KO cells; Figure 1E , also see Figure S1C for heatmaps of the top 100 DE genes in each KO condition) but has a much milder effect on gene expression than observed for BAP1 KO. In addition, loss of ASXL1 or ASXL2 does not affect the localization of BAP1 at chromatin ( Figure S1B ). This result suggests either that BAP1 can function independently of its interaction with ASXL proteins or, alternatively, that the ASXLs are largely redundant.
The ASXL/BAP1 core complex is conserved in mammals
To better understand the function of BAP1, we sought to determine whether it is part of a stable complex and, if it is, with which partners. The purification of Calypso from Drosophila embryos revealed that it forms a heterodimeric complex with ASX 13 . While the interaction between BAP1 and ASXL proteins is conserved 13, 23, 34 , additional partners were reported in the mammalian complex 3,4,9 .
We overexpressed FLAG-tagged versions of BAP1, ASXL1, or ASXL2 in HeLa cells ( Figure S2A ), followed by immunoprecipitation and mass spectrometry. The results confirmed previous reports, in particular the identification of ASXL1/2, FOXK1/2, HCFC1, and KDM1B as partners of BAP1 ( Figure   2A ). The ASXL1 and ASXL2 interactomes are similar with the exception of KDM1B, which is specifically pulled down by ASXL2. Of note, similar results were obtained for the BAP1 interactome in Uveal Melanoma MP41 cells ( Figure S2B ), suggesting that BAP1.com composition is not cell-typedependent.
We then sought to determine whether BAP1 partners are all present in a single complex or if BAP1 is engaged in distinct protein complexes. To this end, we analyzed the elution pattern of BAP1 partners by ion exchange chromatography followed by size-exclusion chromatography (SEC) ( Figure 2B ). The first purification step (ion exchange) revealed that the majority of HCFC1, FOXK1, and KDM1B elute independently of BAP1, which is almost exclusively found in the 500 mM salt fraction, suggesting that only a portion of each of these proteins is engaged in a complex with BAP1. In the second purification step (size-exclusion), we observed that BAP1 elutes with an apparent molecular weight of approximately 500kDa, overlapping with HCFC1, FOXK1, and KDM1B. In contrast, YY1 elutes later and only partially overlaps with BAP1. To know whether the co-elution between BAP1 and its cofactors reflect the assembly of these proteins into a complex, we repeated the experiment with a nuclear extract from BAP1 KO cells. The elution pattern from cation exchange did not reveal any major changes; we therefore continued with SEC. The elution patterns of HCFC1, KDM1B, and FOXK1 remain unchanged indicating that the co-elutions observed with BAP1 in the wild-type extract do not reflect the formation of a stable complex ( Figure 2B ). Considering the previously established tight interaction between BAP1 and the ASXLs 13, 23, 34 , our results suggest that BAP1 and ASXL proteins form a core complex (BAP1.com) which engages in transient interactions with additional partners such as FOXK1/2, HCFC1 or KDM1B ( Figure 2C ). This model predicts that immunoprecipitation of any one of these transient partners would consistently retrieve the core complex but not necessarily other transient partners. Indeed, KDM1B immunoprecipitation from HeLa cells pulls down ASXL2 and BAP1 (as well as NSD3, which is part of a distinct complex with KDM1B) but none of the other transient partners ( Figure S2C ).
ASXLs are required for BAP1 function
Given the role of ASXL1 and ASXL2 in driving BAP1-associated complex composition but the modest effect of their individual deletion on transcription, we wished to investigate their potential redundancy in BAP1-mediated H2A deubiquitination and transcriptional regulation.
To determine whether both proteins also participate in BAP1 function in cells, we generated a double ASXL1/ASXL2 knockout. Of note, ASXL3 is not expressed in wild-type HAP1 cells nor in ASXL1/2 double knockout cells ( Figure S3A ). We first evaluated the effect of this double knockout on chromatin regulation and observed a robust increase in H2A ubiquitination levels similar to those observed in the BAP1 knockout ( Figure 3A ). This result is consistent with the fact that interaction with the ASXLs is required for BAP1 enzymatic activity ( Figure S3B ). Notably, loss of ASXL1 and ASXL2 also led to a dramatic reduction in BAP1 protein levels, indicating that the ASXLs are not only necessary for the enzymatic activity of BAP1 but also for its stability in vivo ( Figure 3A) . Consistent with this effect on BAP1 protein accumulation, transcriptome analysis of ASXL1/2 dKO cells revealed a major impact on gene expression ( Figure 3B ). Similarly to BAP1 KO, most differentially expressed genes were downregulated (1073 downregulated genes out of 1576 DE genes, also see Figure S3C for heatmaps of the top 100 DE genes) and there was a large overlap between genes downregulated in BAP1 KO and ASXL1/2 dKO cells ( Figure 3C ). In comparison, the overlap between upregulated genes was much less pronounced ( Figure 3D ), supporting the idea that the main role of BAP1.com is to promote transcription.
We then wondered if the function of BAP1 in regulating gene transcription requires its deubiquitinase activity. For this purpose, we performed rescue experiments in BAP1 KO cells, reintroducing either wild-type BAP1 or a catalytically dead version (BAP1 C91S). Both versions of BAP1 were reexpressed at a similar level, slightly higher than the original endogenous level ( Figure 3E , upper panel).
Focusing on a selection of genes whose expression is dramatically reduced in the absence of BAP1, reexpression of wild-type BAP1 protein restores up to 75% of the wild-type levels of the transcripts while the C91S mutant is unable to rescue transcription of the tested genes ( Figure 3E , lower panel).
Altogether, these results demonstrate that BAP1 associates with the ASXL proteins to promote transcription in a manner that depends on its enzymatic activity.
BAP1 does not participate in Polycomb-mediated silencing
The data presented above suggest that the main role of BAP1 is to positively regulate transcription.
While this is in agreement with several previously published studies, it contrasts with a number of reports suggesting that BAP1 and ASXL proteins participate in Polycomb-mediated silencing [24] [25] [26] [27] [28] . To formally investigate the interplay between BAP1 and Polycomb proteins, we analyzed the consequences of BAP1 loss in conjunction with loss of RING1B and EZH2, key members of PRC1 and PRC2, respectively ( Figure 4A ).
As expected, the main impact of inactivating either RING1B or EZH2 is the transcriptional upregulation of a large set of genes ( Figure S4A and S4B). The GO terms of the differentially expressed genes (either up-or downregulated) in EZH2 KO cells partially overlap the categories observed upon BAP1 KO such as terms related to signaling or development ( Figure S4C to Figure 1D , right panel). The terms associated with genes differentially expressed in the absence of RING1B are broader, which might reflect a less developmental specific function of PRC1 ( Figure S4D ). To further compare transcriptional changes among all KO conditions, we performed a principal component analysis (PCA, Figure 4B ). Figure 4C , only a minority of the genes regulated by PRC1 and/or PRC2 become upregulated upon loss of BAP1. To determine whether this limited overlap nonetheless reflects a synergistic action of BAP1 with the Polycomb machinery, we investigated chromatin changes occurring at genes upregulated in BAP1 KO. If BAP1
functions together with the Polycomb machinery to maintain transcriptional silencing at a subset of Polycomb target genes, loss of BAP1 is expected to result in a decrease in the Polycomb-mediated chromatin signature. However, chromatin-immunoprecipitation followed by deep sequencing (ChIPseq) did not reveal a decrease in Polycomb histone marks H2AK119ub1 or H3K27me3 at these genes in BAP1 KO cells ( Figure 4D ). In fact, H2AK119ub1 increased, possibly reflecting the more global increase of the mark caused by loss of BAP1. As expected, transcriptional upregulation corresponded with marked increase in H3K4me3, a histone mark deposited preferentially near the 5' ends of transcriptionally active genes. These results suggest that transcriptional upregulation occurring upon BAP1 loss is not caused by impaired Polycomb-mediated silencing. Instead we believe that these gene expression changes are secondary effects of widespread transcriptional downregulation.
Finally, since previous studies have reported a crucial role for the ASXLs in H3K27me3 deposition [24] [25] [26] [27] [28] , we further analyzed the genomic distribution of H3K27me3 in wild-type, BAP1, ASXL1, ASXL2, and EZH2 KO conditions. As shown in Figure 4E , there is a good genome-wide correlation in the localization of the mark between wild-type, BAP1, ASXL1 and ASXL2 KO cells, suggesting that loss of the ASXL proteins does not globally affect H3K27me3 distribution (see also Figure S4E for an example snapshot). This analysis, together with the lack of change in H3K27me3 abundance in BAP1, ASXL1, or ASXL2 KO cells ( Figure 2C ), rules out an essential role for BAP1 and ASXL proteins in PRC2 function, challenging the notion that BAP1 critically participates in Polycomb-mediated silencing.
Polycomb-antagonistic and -independent role of BAP1 in promoting transcription
As shown above, the major impact of loss of BAP1 is the downregulation of gene expression. A straightforward explanation of this effect on gene transcription lies in BAP1 deubiquitinase activity of the PRC1-deposited histone mark, H2AK119ub1. Although H2AK119ub1 has been suggested to be dispensable for gene silencing, it has also been reported to stimulate PRC2 recruitment and to locally promote H3K27me3 deposition 20,21,35 .
To investigate whether BAP1 inactivation indeed results in a gain in Polycomb function, we analyzed genes that are downregulated in the absence of BAP1 ( Figure 5A ). As expected, H3K4me3 decreased concomitantly with transcriptional downregulation. In contrast, both H2AK119ub1 and H3K27me3 significantly increased. In principle, increased levels of these repressive marks could be a direct consequence of the loss of BAP1 deubiquitinase activity or a secondary event due to transcriptional downregulation 36 . In the first case, the Polycomb machinery is expected to contribute to transcriptional silencing, whereas in the second case it is unlikely to be required. To discern between these two possibilities, we genetically inactivated EZH2 in BAP1 KO cells ( Figure 5B ) to determine whether EZH2 deletion can restore the expression of genes that have been downregulated as a consequence of BAP1 loss. Of note, EZH2 deletion in cells already KO for BAP1 did not impair proliferation ( Figure   5C ), consistent with recent evidence challenging the reported synthetic lethal relationship between EZH2 inhibition and BAP1 inactivation 29, 37 . More importantly, of the 913 genes downregulated upon BAP1 KO, a large majority (741 genes) remain silent in the BAP1/EZH2 double KO ( Figure 5D , top heatmap) while the expression of a minority (172 genes) is increased in the double KO compared to BAP1 single KO cells ( Figure 5D , bottom heatmap). This set of genes is also upregulated upon deletion of EZH2 in a BAP1 wild-type context, indicative of a balanced antagonistic regulation by BAP1 and EZH2 ( Figure 5D and 5E). Moreover, all genes downregulated in the absence of BAP1 (i.e.
whether or not they are sensitive to loss of EZH2) gain H2AK119ub1 and H3K27me3 upon BAP1 knockout ( Figure 5F , see also Figure 5G and Figure S5 for specific examples), suggesting that this gain in repressive marks is a consequence rather than a cause of transcriptional downregulation. Thus, although BAP1 and Polycomb proteins act in an opposite fashion at a number of genes, BAP1
promotes gene expression in a way that is largely independent of an antagonism with the Polycomb machinery.
Functional overlap between BAP1.com and general co-activators
Having analyzed the impact of loss of BAP1.com on steady state gene transcription, we next sought to examine its role in transcriptional activation in response to a transcriptional stimulus. Considering previous reports suggesting that BAP1 may modulate nuclear receptor mediated gene regulation 38,39 , we investigated whether deletion of BAP1 would affect response to retinoic acid (RA) treatment. We initially performed a time-course analysis of two of the best-characterized direct RA transcriptional targets: RARβ and CYP26A1 ( Figure 6A ). In contrast to the above-mentioned reports that suggest a repressive role for BAP1.com at RA target genes, we observed that activation of both RARβ and CYP26A1 was severely compromised in BAP1 KO cells. Of note, loss of BAP1 did not affect the protein levels of RARα, a major RA-binding nuclear receptor ( Figure S6A ). To determine whether these results reflect a general role for BAP1 in the transcriptional response to RA, we analyzed the transcriptome of WT and BAP1 KO cells in response to RA treatment (after 24 h). Nearly twice as many genes were significantly activated upon RA treatment in WT than in BAP1 KO cells (n=88 versus n=47, FDR < 0.05 and absolute log2 fold-change > 1, figure S6B ). Furthermore, analyzing the entire set of genes activated in either condition, we found that the response to RA is significantly attenuated in BAP1 KO cells ( Figure 6B ), demonstrating that BAP1 is required for optimal RAmediated transcriptional activation. In contrast to the situation in Drosophila, our results argue against an implication of BAP1.com in the Polycomb machinery. Instead, the picture that emerges from this work is that the function of BAP1.com is to promote transcription. This property may not be surprising given that the activity of the complex is opposite to that of PRC1 in the regulation of H2A ubiquitination and that PRC1 and ASXL1 show rather distinct localization patterns 9 . Our findings are also in line with previous studies using artificial recruitment of BAP1 to a transgene 3 , overexpressing hyperactive forms of ASXL1 41 or focusing on individual loci 30 . We observed that a set of genes is antagonistically regulated by BAP1.com and the Polycomb machinery. However, this antagonism only occurs at a minority of BAP1-regulated genes and both regulatory activities seem to act independently of each other. Overall, BAP1.com mostly regulates the expression of genes that are not under the regulation of Polycomb proteins. As such, BAP1 does not appear to act as an anti-repressor, as described for the Trithorax and Ash1 histone methyltransferases 42 , but rather as a general transcriptional co-activator. An obvious question arising from these results is whether BAP1 and Calypso have divergent functions or whether we can reconcile their proposed contributions to gene regulation in both species. First, it is noteworthy that there is no consensus as to whether the Calypso-Asx complex is generally involved in Polycombmediated silencing. Indeed, mutation of Asx in Drosophila leads to a complex phenotype that exhibits features of both Polycomb and Trithorax mutants 43 , a situation that is also found in Asxl1 mutant mouse embryos 44 . Second, only a subset of Polycomb target genes was found to be aberrantly activated upon loss of Asx or Calypso 45 . Third, part of the difference might result from the extent to which BAP1 and Calypso regulate H2A ubiquitination. While loss of Asx leads to an approximate 10-fold increase in the total levels of H2AK118ub1 22 , we only observe an approximate 2-fold increase in the level of the mark upon inactivation of either of BAP1 or ASXL1/2. This suggests that in In conclusion, our work provides novel insight into the function of BAP1.com and paves the way for further work to elucidate the molecular mechanism linking BAP1 activity to stimulation of transcription.
Materials and methods
Cell lines
HAP1 cells were kindly provided by Dr T. Brummelkamp and cultured in IMDM media supplemented with 10% FBS and 1% L-Glutamine. MP41 cells were kindly provided by Dr S. Roman-Roman and cultured in RPMI media supplemented with 10% FBS and 1% L-Glutamine (Invitrogen). HeLa-S3 cells were kindly provided by Dr S. Ait-Si-Ali. They were cultured in adherence in DMEM media supplemented with 10% FBS and 1% L-Glutamine. Non-adherent culture of HeLa cells was performed in DMEM media supplemented with 5% FBS and 1% L-Glutamine following guidelines from Nakatani and Ogryzko 47 . SF9 cells were cultured in SF-900 II SFM medium (Invitrogen)
supplemented with 5% FBS, 1% Penicillin/Streptomycin (Invitrogen) and Amphotericin B at 28° C.
Constitutive knockouts in HAP1 cell line
Mutations of BAP1, ASXL1, ASXL2, EZH2, and SMARCB1 in HAP1 cells were performed using CRISPR/CAS9 technology as described in 33 . The selected clones were thus used as constitutive knockouts, using the parental cell line as a control in all experiments. RING1B and CREBBP KO HAP1 cells were purchased from Horizon Discovery.
Stable expression in HeLa cells
For mass spectrometry analysis of Flag-tagged BAP1, ASXL1, ASXL2, and KDM1B in HeLa cells, cDNAs encoding the different proteins were first subcloned in pRev retroviral plasmid (gift from S.
Ait-Si-Ali), downstream a 2xFlag-2xHA sequence and upstream an IRES sequence followed by CD25
cDNA. Retroviruses were produced by transfection of a 293 Phoenix cell line (gift from S. Ait-Si-Ali)
and HeLa-S3 cells were infected by incubation with viral supernatants for 3 hours at 37°C. Infected cells were then selected by FACS sorting against CD25 expression using CD25-FITC antibody and following manufacturer's instructions (BD Biosciences 553866). Expression was assessed by western blot analysis of nuclear extracts.
Rescue experiment (BAP1 WT and C91S)
Reintroduction of wild-type or enzymatically dead (C91S) BAP1was performed by infection of BAP1
KO cells with a pBABE retrovirus produced as previously described 48 .
Proliferation assays
50000 cells were plated in 6 well plates in triplicates and counted every 24 hours over 4 days using a Vi-cells counter (Beckman-coulter).
RT-qPCR
Total RNA was isolated using Trizol-Chloroform extraction and isopropanol precipitation. cDNA was synthetized using High Capacity cDNA RT kit (4368814-Applied Biosystems) and quantitative PCR was performed with technical triplicate using SYBR green reagent (Roche) on a ViiA7 equipment (Applied Biosystems). At least three independent experiments (biological replicate) were performed for each assay and RT negative controls were always included. Primer sequences for qPCR analysis are provided in supplemental table 1.
RNA sequencing
Two biological independent RNA sequencing were performed for each condition. 100bp single end reads were generated for the retinoic acid analysis and 100bp paired-end reads for all other samples using the HiSeq 2500 platform. Raw reads were trimmed with cutadapt (1. 
Differential Expression Analysis
Genes with 0 counts across all samples and CPM < 0.5 in less than 3 samples were removed. Raw library sizes were scaled using the TMM method with edgeR (3.18.1; (McCarthy, 2012 #15234)) and counts were transformed to log2-counts per million (logCPM) with limma (3.32.7). A linear model was fit to the normalized data and empirical Bayes statistics were computed for each knockout versus wildtype or rescue. Differentially expressed genes were identified from the linear fit after adjusting for multiple comparisons and filtered to include those with FDR < 0.05 and absolute logFC > 1.
Gene ontology enrichment analysis was performed with goseq (1.28.0) using the Wallenius method to calculate a probability weighting function for top differential genes as a function of a gene's median transcript length. GO terms with FDR < 0.01 were collapsed in REVIGO.
CREBBP, SMARCA4, BAP1 Analysis
Raw data for SMARCA4 and WT were downloaded from GEO (GSE75515). RNA-seq analysis was performed as described previously.
Chromatin immuno-precipitation
ChIPs were performed as described previously 55 . Cell confluence and amount of starting material were kept constant by plating defined number of cells two days before cross-linking.
ChIP sequencing
100bp single-end reads were generated using the HiSeq2500 platform. Reads were mapped to the human reference genome (GRCh37/hg19) with Bowtie2 (2.2.9) using default parameters. PCR duplicates were removed with Picard Tools MarkDuplicates (1.97;
http://broadinstitute.github.io/picard): VALIDATION_STRINGENCY=SILENT REMOVE_DUPLICATES=true. Total uniquely mapping reads were calculated using RSeQC bam_stat.py (2.6.4). bigWig files were generated with deepTools bamCoverage (2.4.1). Read counts were normalized using a scale factor of 1000000/total reads per sample and artifact regions were excluded. The merged consensus blacklist was obtained from the Kundaje lab at Stanford University (USA).
Scores 5kb upstream and downstream of TSSs were computed from normalized bigWig files with deepTools computeMatrix (2.4.1) using reference-point mode. TSS plots were generated with deepTools plotHeatmap (2.4.1).
PolII, BAP1 and ASXL1 ChIP-seq analysis
Raw data were downloaded from GEO (GSE40723, GSE36027, GSE51673, and GSE31477). FASTQ files were merged for samples with multiple runs and mapping was performed as previously described to hg19 or mm10. bigWig files were generated with deepTools bamCoverage (2.4.1). Artifact regions were excluded and read counts were normalized to log2(sample/input).
The merged consensus blacklists for hg19 and mm10 were obtained from the Kundaje lab at Stanford University (USA): ftp://encodeftp.cse.ucsc.edu/users/akundaje/rawdata/blacklists/ Average values per TSS +/-2kb were computed using deepTools multiBigwigSummary and correlation plots for these regions were generated with deepTools plotCorrelation (--corMethod pearson -removeOutliers -skipZeros).
Antibodies BAP1 (C-4; sc-28383), FOXK1 (G-4; sc-373810), YY1 (sc-7341) and RAR-alpha (sc-551X) were purchased from Santa-Cruz; FLAG (M2; F1804) was purchased from Sigma; HCFC1 (A301-400A) and RNF2 (A302-869A) were purchased from Bethyl Laboratories; Lamin B1 (ab16048); H2AK119ub (D27C4; 8240S), H3K27me3 (C36B11, 9733S), H3K4me3 (C42D8, 9751) were purchased from Cell
Signaling; H2B (5HH2-2A8; 61037); H2BK120Ub (C56; 39623), H3 (C-terminal; 39163), KDM1B
(61457) were purchased from Active Motif; H3K4me2 (MCA-MAB10003-100-Ex) was purchased from Cosmo Bio; alpha-Tubulin (1F4E3; A01410) was purchased from Genscript.
Histone extraction
Cells were lysed in a hypotonic lysis buffer (10mM Tris pH6.8, 50mM Na2SO4, 1%Triton X-100, 
Nuclear Extracts (High salt)
For nuclear extract preparation, cells were incubated with buffer A (10mM Hepes pH 7.9, 2.5mM
MgCl2, 0.25M sucrose, 0.1% NP40 and protease inhibitors) for 10 min on ice, centrifuged at 8000 rpm for 10 min, resuspended in buffer B (25mM Hepes pH 7.9, 1.5mM MgCl2, 700 mM NaCl, 0.1 mM EDTA, 20% glycerol and protease inhibitors), sonicated and centrifuged at 14000 rpm for 15min.
Chromatography analyses
For analysis of endogenous protein profiles in HAP1 cells, nuclear extracts (High salt) were first dialyzed against BP100 (50mM Potassium Phosphate pH 6,8, 100mM NaCl, 1mM EDTA, 1mM DTT, protease inhibitors) and clarified by high-speed centrifugation. Samples were then purified by ion exchange chromatography using a HiTrap SP HP 5ml column (GE Healthcare). Elution was performed by step elution with increasing NaCl concentration. 500mM elution was concentrated 5X time on centricon (Millipore, cut-off 10kDa) and analyzed on Superose 6 PC 3.2 increase column (GE Healthcare). The native molecular size markers used for column calibration were thyroglobulin (669 kDa), ferritin (440 kDa) and aldolase (158 kDa).
Mass spectrometry analysis
For mass spectrometry analysis of Flag-tagged constructs overexpressed in HeLa cells, 100mg of nuclear extracts were used. Nuclear extracts were first dialyzed in BC250 (50mM Tris pH8.0, 250mM
KCl, 1mM EDTA, 10% Glycerol and protease inhibitors). Precipitates were removed by centrifugation and the supernatant was incubated with anti-FLAG M2 affinity gel overnight. The beads were then washed three times with BC250 + 0,05% NP40 and eluted with 0,2mg/ml Flag peptide, precipitated with ice-cold acetone and resuspended in 1X Laemmli Sample Buffer. Of note, for mass spectrometry analysis of Flag-tagged BAP1 overexpressed in MP41 cells, 50 mg of nuclear extracts was used and first purified on an ion exchange chromatography HiTrap Q 1ml column (GE Healthcare).
After IP and elution of enriched proteins, SDS-PAGE (Invitrogen) was used without separation as a cleanup step to remove lipids, metabolites, salts, and denaturing agents from the samples. After colloidal blue staining (LabSafe GEL BlueTM GBiosciences), 4 gel slices were excised and proteins were reduced with 10 mM DTT prior to alkylation with 55 mM iodoacetamide. After washing and shrinking the gel pieces with 100% MeCN, in-gel digestion was performed using trypsin/Lys-C (Promega) overnight in 25 mM NH4HCO3 at 30°C.
Peptides were extracted and analyzed by nanoLC-MS/MS using an RSLCnano system (Ultimate 3000, Thermo Scientific) coupled to an Orbitrap Fusion mass spectrometer (Q-OT-qIT, Thermo Fisher Scientific). Samples were loaded on a C18 precolumn (300 µm inner diameter x 5 mm; Dionex) at 20 µl/min in 2% MeCN, 0.05% TFA. After a desalting for 3 min, the precolumn was switched on the C18
column ( ms. Only those precursors with charge state 2-7 were sampled for MS2. The dynamic exclusion duration was set to 60s with a 10ppm tolerance around the selected precursor and its isotopes. The instrument was run in top speed mode with 3 s cycles.
Data were searched against the uniprot-Human database, using Sequest HT from Proteome Discoverer 1.4 (thermo Scientific). Enzyme specificity was set to trypsin and a maximum of two miss cleavages was allowed. Oxidized methionine, N-terminal acetylation and carbamidomethyl cysteine were set as variable modifications. The mass tolerances in MS and MS/MS were set to 10 ppm and 0.6 Da, respectively. The resulting files were further processed using myProMS 56 . The Sequest HT target and decoy search results were validated at 1% FDR with Percolator.
DNA methylation analysis
Genomic DNA was extracted following manufacturer protocol (DNA easy, Qiagen), treated with RNAse A and RNAse T1, purified again and quantified using nanodrop. 1 microgram of DNA was then digested by the degradase plus (Zymoresearch), ethanol precipitated and the supernatant was then evaporated on speedvac. Samples were then reconstituted in 10 µl of solution A' (2% methanol, 0.1% HCOOH), vortex-mixed, centrifuged and transferred to a HPLC vial for micoLC-MS/MS analysis.
Fractions were used directly in solution A' and analyzed (5 µL) using the RSLCnano system connected to the Orbitrap Fusion mass spectrometer. Sample separation was achieved on a C18 column (4.6 x 100 mm, packed with ZORBAX Eclipse XDB C18, 1. 
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